Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07215390 |
| Consolidated Lead Sponsor | Apellis Pharmaceuticals |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 240 participants (ESTIMATED) |
| Registered Start Date | 2025-06-23 |
| WhyStopped Classification | Not Stopped |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.